Thoratec Corporation, and HeartWare International, Inc., In the Matter of

Last Updated:
In the Matter of Thoratec Corporation, a corporation, and HeartWare International, Inc., a corporation.
FTC Matter/File Number:


Docket Number:


Enforcement Type:

Federal Injunctions

Case Summary

The Commission authorized a preliminary injunction to block Thoratec Corporation’s proposed $282 million acquisition of rival medical device maker HeartWare International, Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (LVADs), a life-sustaining treatment for patients with advanced heart failure. The FTC’s administrative complaint alleges that Thoratec seeks to maintain its monopoly by acquiring HeartWare, thus eliminating the only significant threat to Thoratec’s continued dominance of the LVAD market.  In August of 2009, the parties announced they would not to proceed with the proposed acquisition, and the Commission dismissed the Administrative Complaint without filing an motion for preliminary injunction in federal court.